References:
Biziulevicius, G.A. (2006). “Where do the immunostimulatory effects of oral proteolytic enzymes (“systemic enzyme therapy) come from? Microbial proteolysis as a possible starting point.” Med. Hypotheses, 67, 1386-1388.

Dittmar, F.W. & Weissenbacher, E.R. (1992). “Therapy of adnexitis - enhancement of the basic antibiotic therapy with hydrolytic enzymes.” Int. J. Expl. Clin. Chemother., 5, 73-81.

Akhtar, N.M, Naseer, R., Farooqi, A.Z., Aziz, W. & Nazir, M. (2004). “Oral enzyme combination versus diclofenac in the treatment of the knee - a double-blind prospective randomized study.” Clin. Rheumatol., 23, 410-415.

Baerwald, C., Willeke, A., Lies, S. & Goebel, K.M. (1999). “Efficacy and tolerance of oral hydrolytic enzymes in ankylosing spondylitis as compared with indomethacin: a controlled double-blind prospective clinical trial.” J. Clin. Res., 2, 17-34.

Klein, G., Kullich, W., Schnitker, J. & Schwann, H. (2006). “Efficacy and tolerance of an oral enzyme combination in painful osteoarthritis of the hip. A double-blind, randomised study comparing oral enzymes with non-steroidal anti-inflammatory drugs.” Clin. Exp. Rheumatol., 2, 55-60.

Mazourov, V.I., Lila, A.M., Klimko, N.N., Raimuev, K.V. & Makulova, T.G. (1997). “The Efficacy of Systemic Enzyme Therapy in the Treatment of Rheumatoid Arthritis.” Int. J. Immunotherapy, XIII, 85-91.

Shaikov, A.V., Movsisyan, R.G. & Stolyara, A.V. (1997). “Wobenzym in the treatment of Patients with juvenile chronic arthritis.” Int. J. Immunotherapy, XIII, 93-96.

Wittenborg, A., Bock, P.R., Hanisch, J., Saller, R. & Schneider, B. (2000). “Comparative Epidemiological Study in Patients with Rheumatic Diseases Illstrated in an Example of a Treatment with Non-Steroidal Anti-inflammatory Drugs versus an Oral Enzyme Combination.” Arzneim.-Forschung/Drug Res., 50, 728-738.

Leipner, J., Iten, F. & Saller, R. (2001). “Therapy with Proteolytic Enzymes in